NSAIDs: can the presence of infectious agent influence the choice of analgesic drug?
DOI:
https://doi.org/10.14739/2310-1237.2017.2.109671Keywords:
NSAIDs, comorbidity, analgesicsAbstract
Purpose. Considering the significant prevalence of comorbid pathology there is a high probability of NSAID use in patients with concomitant infection. In view of this screening of antimicrobial properties of their main groups was conducted for the purpose of selecting the most promising ones for further in-depth study.
Materials and methods. The study of microorganisms’ sensitivity was conducted using standard research methods – the method of "wells" and by determining the antibacterial properties of drugs, using tablets, based on the ability of the drug to diffuse into agar, used for sowing the test-culture. As the test cultures S. aureus, S. mutans, S. pyogenes, P. aeruginosa, E. Coli, isolated from patients who were treated in hospital were used. Predominant blocker of COX-1 (acetylsalicylic acid, ASA), nonselective blockers of COX-1 and COX-2 (ketorolac, diclofenac sodium, ibuprofen, mefenamic acid, dexketoprofen), predominant blockers of COX-2 (meloxicam and nimesulide), selective blockers of COX-2 (celecoxib), selective blockers of COX-3 (COX-1 in the brain) paracetamol and metamizole were tested.
Results. The studies found that most of the tested NSAIDs have antimicrobial activity. Leader drugs in expressiveness of antimicrobial effects are drugs that have sufficient COX-1 (3) - activity: ASA, diclofenac, dexketoprofen, metamizole, and lesser extent – paracetamol. Tested NSAIDs showed the highest activity against gram-positive coccal flora, mostly affecting S. Pyogenes. Blockers of COX-3 paracetamol and metamizole, unlike other studied drugs, showed stronger antipseudomonal (both – moderate) and antistaphylococcal action (metamizole).
Conclusions. NSAIDs with antimicrobial activity can potentially increase the activity of antiinfectious therapy. At the same time, the antimicrobial activity of NSAIDs, theoretically, can promote microbial resistance because of existence of microorganisms in a medium with subthreshold concentrations of drugs with antimicrobial activity. Considering this, further clinical and pharmacological research of this problem has a great practical importance.
References
Bryant, A. E., Bayer, C. R., Aldape, M. J., & Stevens, D. L. (2015). The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections. Curr Opin Infect Dis, 28(3), 231–239. doi: 10.1097/QCO.0000000000000160.
Mazumdar, K., Mazumdar Dastidar, S. G., Park, J. H., & Dutta, N. K. (2009). The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target. Eur J Clin Microbiol Infect Dis, 28(8), 881–891. doi: 10.1007/s10096-009-0739-z.
Dutta, N. K., Mazumdar, K., Dastidar, S. G., & Park, J. H. (2007). Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Int J Antimicrob Agents, 30(4), 336–340. doi: 10.1016/j.ijantimicag.2007.04.016.
Habrieva, R. U. (2005). Rukovodstvo po e´ksperimental'nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv [Manual on experimental (pre-clinical) study of the new pharmacological substances]. Moscow. [in Russian].
Nunes, C., Brezesinski, G., Pereira-Leite, C., Lima, J. L., Reis, S., & Lúcio, M. (2011). NSAIDs interactions with membranes: a biophysical approach. American Chemical Society, 27(17), 10847–10858. doi: 10.1021/la201600y.
Osthoff, M., Sidler, J. A., Lakatos, B., Frei, R., Dangel, M., Weisser, M., et al. (2016). Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Cohort Study. Crit Care Med, 44(4), 773–781. doi: 10.1097/CCM.0000000000001554.
Hendrixa, A. S., Spoonmore, T. J., Wilde, A. D., Putnama, N. E., Hammerc, N. D., Snydera, D. J., et al. (2016). Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. Antimicrob Agents Chemother, 22, 60(9), 5322–5330. doi: 10.1128/AAC.00834-16.
Dastidar, S. G., Ganguly, K., Chaudhuri, K., & Chakrabarty, A. N. (2000). The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents, 14(3), 249–251. doi: https://doi.org/10.1016/S0924-8579(99)00159-4.
Viehmann, M., Postiasi, S., Balka, G., Spergser, J., Palzer, A., Hennig-Pauka, I., et al. (2013). Evaluation of the efficacy of a combination therapy of an antibiotic and a NSAID following an experimental Haemophilus parasuis infection in nursery piglet. Tierarztl Prax Ausg G Grosstiere Nutztiere, 41(4), 225–232.
Annamanedi, M., & Kalle, A. M. (2014). Celecoxib sensitizes Staphylococcus aureus to antibiotics in macrophages by modulating SIRT1. PLoS One, 9(6), e99285. doi: 11.1371/journal.pone.0099285.
Arunasree, M. K., & Arshad, Rizvi. (2011). Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor. Antimicrob Agents Chemother, 55(1), 439–442. doi: 10.1128/AAC.00735-10.
Krause, J., Geginat, G., & Tammer, I. (2015). Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms. PLoS One, 10(8), e0135404. doi: 10.1371/journal.pone.0135404.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
